News Releases
- Algernon Pharmaceuticals Provides Final Summary on Accelerated Warrants January 22, 2021
- Algernon Pharmaceuticals Provides Reminder on Expiry Date of Accelerated Warrants January 19, 2021
- Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19 January 19, 2021
- Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment January 11, 2021
- Algernon Pharmaceuticals Announces Plans for 2021 January 7, 2021
- Algernon Pharmaceuticals Provides Year End Summary of Key Activities December 30, 2020
- Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 December 24, 2020
- Algernon Pharmaceuticals Announces Acceleration of Expiry Date of Warrants December 24, 2020
- Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast December 21, 2020
- Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data December 17, 2020